Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 419

1.

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.

Oreja-Guevara C, Ramos-Cejudo J, Aroeira LS, Chamorro B, Diez-Tejedor E.

BMC Neurol. 2012 Sep 18;12:95. doi: 10.1186/1471-2377-12-95.

2.

Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate.

Tumani H, Kassubek J, Hijazi M, Lehmensiek V, Unrath A, Süssmuth S, Lauda F, Kapfer T, Fang L, Senel M, Brettschneider J.

Eur Neurol. 2011;65(3):164-9. doi: 10.1159/000324035.

PMID:
21372576
4.
5.

Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.

Chen M, Gran B, Costello K, Johnson K, Martin R, Dhib-Jalbut S.

Mult Scler. 2001 Aug;7(4):209-19.

PMID:
11548979
6.

Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.

Dhib-Jalbut S, Chen M, Said A, Zhan M, Johnson KP, Martin R.

J Neuroimmunol. 2003 Jul;140(1-2):163-71.

PMID:
12864985
7.

Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.

Sellner J, Greeve I, Findling O, Kamm CP, Minten C, Engelhardt B, Grandgirard D, Leib SL, Mattle HP.

Neurochem Int. 2008 Jul;53(1-2):17-21. doi: 10.1016/j.neuint.2008.04.004.

PMID:
18524417
8.

Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.

Dhib-Jalbut S, Chen M, Henschel K, Ford D, Costello K, Panitch H.

Mult Scler. 2002 Dec;8(6):485-91.

PMID:
12474988
9.

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?

Gómez D, Correa PA, Gómez LM, Cadena J, Molina JF, Anaya JM.

Semin Arthritis Rheum. 2004 Jun;33(6):404-13.

PMID:
15190525
10.

Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis.

Fellay B, Chofflon M, Juillard C, Paunier AM, Landis T, Roth S, Gougeon ML.

Immunology. 2001 Dec;104(4):383-91.

11.

Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.

Valenzuela RM, Costello K, Chen M, Said A, Johnson KP, Dhib-Jalbut S.

Mult Scler. 2007 Jul;13(6):754-62.

PMID:
17613604
12.

IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines.

Sega S, Wraber B, Mesec A, Horvat A, Ihan A.

Clin Neurol Neurosurg. 2004 Jun;106(3):255-8.

PMID:
15177779
14.

Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.

Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.

J Rheumatol. 2000 May;27(5):1128-35.

PMID:
10813277
15.

Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?

Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.

Int Immunol. 2006 Apr;18(4):537-44.

16.

Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation.

Miller A, Shapiro S, Gershtein R, Kinarty A, Rawashdeh H, Honigman S, Lahat N.

J Neuroimmunol. 1998 Dec 1;92(1-2):113-21.

PMID:
9916886
18.

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.

Song C, Halbreich U, Han C, Leonard BE, Luo H.

Pharmacopsychiatry. 2009 Sep;42(5):182-8. doi: 10.1055/s-0029-1202263.

PMID:
19724980
19.

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, Murai H, Kira J.

PLoS One. 2013 Apr 18;8(4):e61835. doi: 10.1371/journal.pone.0061835.

20.

Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.

Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.

J Neurol Sci. 2004 Jul 15;222(1-2):65-73.

PMID:
15240198
Items per page

Supplemental Content

Support Center